Current Outcomes of NIH T32 GM068411 Graduate Student Trainees
Over a span of 15 years, 86 graduate students have been supported by this NIGMS training grant (T32 GM068411). Of those trainees, 64 have graduated with a PhD degree, including 8 who have earned MD/PhD degrees through our Medical Student Training Program (MSTP), 7 have earned an MS degree, and 15 are still in training.
Of our 64 trainees who have earned a PhD degree, 33% are in primarily research careers, 20% are in research-related careers, 6% are in primarily teaching positions, 9% are in primarily clinical positions, 25% are furthering their training (through research-intensive postdoctoral positions), and the remaining 6% (4 individuals) are pursuing other careers.
The average time-to-degree for the 64 trainees who have earned a PhD degree was 5 years and 2 months.
Current Status of all T32 Trainees
Below is a summary of all trainees supported by the NIGMS T32 by participating graduate program.
|
T32 Participating Program* |
Total T32 Trainees |
PhD |
MD1 |
MS2 |
In Training |
|
Biochemistry & Molecular Biology (BMB) |
44 |
32 |
2 |
3 |
9 |
|
Biophysics, Structural & Computational Biology (BSCB) |
18 |
12 |
1 |
4 |
2 |
|
Cellular and Molecular Pharmacology & Physiology (CMPP) |
11 |
9 |
1 |
0 |
2 |
|
Immunology, Microbiology & Virology (IMV) |
13 |
11 |
4 |
0 |
2 |
|
TOTALS |
86 |
64 |
8 |
7 |
15 |
|
% out of Total Trainees (86) |
|
74% |
9% |
8% |
17% |
1All 8 trainees in our MD/PhD Program have completed their training are counted in both “PhD” and “MD” columns above.
2Those listed as having obtained an MS did not go on to obtain a PhD or MD through our programs.
T32 Trainee Outcomes by Program
Below is a summary of the career paths of the 64 trainees who have obtained a PhD through the NIGMS T32 Program.
|
T32 Participating Program* |
PhD |
MD |
Primarily Research |
Research Related |
Primarily Teaching |
Primarily Clinical |
Further Training |
Unrelated to Research |
|
Biochemistry & Molecular Biology (BMB) |
32 |
2 |
15 |
8 |
3 |
1 |
2 |
3 |
|
Biophysics, Structural & Computational Biology (BSCB) |
12 |
1 |
3 |
4 |
0 |
1 |
3 |
1 |
|
Cellular and Molecular Pharmacology & Physiology (CMPP) |
9 |
1 |
3 |
0 |
0 |
1 |
5 |
0 |
|
Immunology, Microbiology & Virology (IMV) |
11 |
4 |
0 |
1 |
0 |
3 |
6 |
0 |
|
TOTALS |
64 |
8 |
21 |
13 |
4 |
6 |
16 |
4 |
|
% out of Total Graduated Trainees (64) |
33% |
20% |
6% |
9% |
25% |
6% |
*Please Note: The 8 MSTP trainees who obtained their MD have also obtained their PhD and are counted in both categories.
Former T32 trainees who’ve earned their PhDs have worked initially or currently on furthering their training as postdocs or residents at the following institutions and centers:
- Albany College of Pharmacy
- Biomedical Advancement Research and Development Authority
- Boston Children's Hospital
- Case Western Reserve
- Cincinnati Children's Hospital Medical Center
- Coriell Institute for Medical Research
- Cornell University
- Emory University
- Harvard Medical School
- Harvard School of Public Health
- Indiana University
- Johns Hopkins School of Medicine
- Max Planck Institute for Biophysical Chemistry
- National Cancer Institute (NCI)
- National Institute of Child Health and Human Development (NICHD)
- National Institute of Environmental Health Sciences (NIEHS)
- National Institute on Aging (NIA)
- National Institutes of Health (NIH)
- Pennsylvania State University
- Purdue University
- Rochester Regional Healthy/Unity Hospital
- Rutgers University
- Stanford University
- Strong Memorial Hospital
- Tufts Medical Center
- University of Alabama
- University of California-San Diego
- University of Kansas
- University of Massachusetts Medical School
- University of Pennsylvania Health System
- University of Rochester Medical Center
- University of Utah
- University of Washington
- University of Wisconsin-Madison
- Washington University
